Balyasny Asset Management
NTUS

Balyasny Asset Management’s Natus Medical Inc NTUS Stock Holding History

Balyasny Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,858
Closed -$454K – 3475
2022
Q2 		$454K Buy
+13,858
New +$438K ﹤0.01% 2008
2020
Q4 		– Sell
-32,025
Closed -$549K – 1828
2020
Q3 		$549K Buy
+32,025
New +$605K ﹤0.01% 1091
2018
Q2 		– Sell
-11,223
Closed -$378K – 2264
2018
Q1 		$378K Buy
+11,223
New +$355K ﹤0.01% 1539
2017
Q1 		– Sell
-6,100
Closed -$212K – 1846
2016
Q4 		$212K Buy
+6,100
New +$239K ﹤0.01% 1275

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Balyasny Asset Management's NTUS Position: Q3 2022 in Review

Balyasny Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 13,858 shares — an estimated $454K sold.

Balyasny Asset Management first reported a position in NTUS in Q4 2016 and held it in 4 quarters. The position peaked at $549K in Q3 2020. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Balyasny Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 13,858 Natus Medical Inc shares in Q3 2022, an estimated $454K.
  • Balyasny Asset Management first reported a position in Natus Medical Inc in Q4 2016 and held it in 4 quarters.
  • Balyasny Asset Management's Natus Medical Inc position peaked at $549K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.